Resource impact report
NICE has produced a resource impact report that incorporates the following technology appraisal guidance for treating chronic kidney disease:
- Empagliflozin for treating chronic kidney disease (2023) NICE technology appraisal guidance 942
- Dapagliflozin for treating chronic kidney disease (2022) NICE technology appraisal guidance 775
This page was last updated: